Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

47.85
Delayed Data
As of Sep 30
 +1.75 / +3.80%
Today’s Change
30.94
Today|||52-Week Range
54.96
+25.39%
Year-to-Date
Intra-Cellular Reports Poor Phase III Schizophrenia Data
Sep 29 / Zacks.com - Paid Partner Content
AcelRx (ACRX) Initiates Phase III IAP312 Study on Zalviso
Sep 28 / Zacks.com - Paid Partner Content
Bristol-Myers, Nektar Tie-Up for Opdivo/NKTR-214 Combo
Sep 28 / Zacks.com - Paid Partner Content
Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III
Sep 28 / Zacks.com - Paid Partner Content
Summit (SMMT): Rare Pediatric Disease Status for DMD Drug
Sep 28 / Zacks.com - Paid Partner Content
Myriad Genetics to Present myRisk Data at Seattle Conference
Sep 28 / Zacks.com - Paid Partner Content
Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug
Sep 28 / Zacks.com - Paid Partner Content
Ionis/Biogen Complete Nusinersen NDA Submission in U.S.
Sep 27 / Zacks.com - Paid Partner Content
Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial
Sep 28 / Zacks.com - Paid Partner Content
Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S.
Sep 27 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close46.10
Today’s open46.37
Day’s range45.89 - 47.98
Volume236,947
Average volume (3 months)123,791
Market cap$707.1M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-19.92%
Earnings growth (this year)-0.66%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-11.93%
P/E ratio20.9
Price/Sales6.29
Price/Book3.41

Competitors

 Today’s
change
Today’s
% change
NVCRNovocure Ltd+0.01+0.12%
KTWOK2M Group Holdings I...+0.48+2.77%
ANGOAngioDynamics Inc+0.53+3.12%
CERSCerus Corp+0.09+1.47%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.47
Annual revenue (last year)$93.0M
Annual profit (last year)$30.8M
Net profit margin33.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts

Search for Jobs